Characteristic | Pts | (%) |
---|---|---|
Age | ||
Median (range) | 57 (24–78) | |
Stage | ||
Ia | 15 | (21.8) |
Ib | 1 | (1.4) |
Ic | 47 | (68.2) |
IIa | 5 | (7.2) |
IIb | 1 | (1.4) |
Histology | ||
Serous | 20 | (29) |
Endometrioid | 18 | (26.1) |
Mucinous | 10 | (14.5) |
Clear cell | 11 | (15.9) |
Poorly differentiated | 5 | (7.2) |
Adenocarcinoma (not specified) | 2 | (2.9) |
Other | 3 | (4.4) |
Grade (n = 66) | ||
1 | 12 | (18.2) |
2 | 36 | (54.5) |
3 | 18 | (27.3) |
Missing | 3 | |
Type of surgery | ||
TAH+BSO | 7 | (10.1) |
TAH+BSO+omentectomy | 51 | (74) |
TAH+BSO+omentectomy+LND | 8 | (11.6) |
BSO+omentectomy | 2 | (2.9) |
BSO | 1 | (1.4) |
Baseline CA125 (n = 59) | ||
Elevated | 20 | (34) |
Normal | 39 | (66) |